Literature DB >> 13370625

Some laboratory and clinical experiences with a new antibiotic, vancomycin.

J E GERACI, F R HEILMAN, D R NICHOLS, G T ROSS, W E WELLMAN.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/effects; BACTERIA/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13370625

Source DB:  PubMed          Journal:  Proc Staff Meet Mayo Clin        ISSN： 0092-699X


× No keyword cloud information.
  25 in total

Review 1.  Approaching and analyzing a large literature on vancomycin monitoring and pharmacokinetics.

Authors:  Patricia Lee; David DiPersio; Rebecca N Jerome; Arthur P Wheeler
Journal:  J Med Libr Assoc       Date:  2007-10

Review 2.  Pharmacokinetic optimisation of the treatment of septic arthritis.

Authors:  K A Hamed; J Y Tam; C G Prober
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

3.  Clostridium difficile colitis secondary to intravenous vancomycin.

Authors:  J R Hecht; E J Olinger
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

4.  Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.

Authors:  J D Knudsen; K Fuursted; S Raber; F Espersen; N Frimodt-Moller
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.

Authors:  J Albanèse; M Léone; B Bruguerolle; M L Ayem; B Lacarelle; C Martin
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 6.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

7.  Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.

Authors:  Nicole J Pultz; Usha Stiefel; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers.

Authors:  D P Healy; R E Polk; M L Garson; D T Rock; T J Comstock
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

9.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

Review 10.  Selective decontamination of the digestive tract: the mechanism of action is control of gut overgrowth.

Authors:  Luciano Silvestri; Miguel A de la Cal; Hendrick K F van Saene
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.